Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$9,797,400
+$355,661 QoQ
Shares Held
38,577
-0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.82%
of 13F equity value
Holder Rank
#1,125
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TCI Wealth Advisors, Inc. holds $24,505,177 across 8 Drug Manufacturers - General names. JNJ ranks #1 (40.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
38,577 | $9,797,400 | |
| 2 | LLY |
ELI LILLY & Co
|
6,824 | $8,184,911 | |
| 3 | ABBV |
AbbVie Inc.
|
15,431 | $3,883,056 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,242 | $1,187,597 | |
| 5 | AMGN |
Amgen Inc
|
1,691 | $612,344 | |
| 6 | PFE |
Pfizer Inc
|
15,257 | $367,388 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,558 | $262,631 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,661 | $209,850 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,797,400 | 38,577 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $9,441,739 | 38,626 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $8,385,200 | 40,518 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $7,550,858 | 40,723 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $6,320,184 | 41,376 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $6,811,048 | 41,070 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $5,491,799 | 37,974 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $6,301,703 | 38,885 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $5,730,641 | 39,208 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $6,088,416 | 38,488 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $6,116,151 | 39,021 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,112,564 | 39,246 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $6,576,109 | 39,730 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $6,186,670 | 39,914 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $7,014,771 | 39,710 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $6,543,711 | 40,057 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $7,060,105 | 39,773 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $7,023,624 | 39,630 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $6,722,537 | 39,297 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $6,668,173 | 41,289 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $6,678,559 | 40,540 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $6,293,618 | 38,294 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $6,379,870 | 40,538 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $7,135,669 | 47,929 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $6,886,932 | 48,972 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $6,513,095 | 49,669 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||